Company Filing History:
8 out of 1,323 
1 out of 5 Years Active: 1996-2006
Title: The Innovative Contributions of Donald E. Korte
Introduction
Donald E. Korte is a notable inventor based in Mundelein, IL (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Korte has made strides in developing compounds that address critical health issues, particularly in the treatment of inflammation.
Latest Patents
Among his latest patents, Korte has developed substituted benzopyran derivatives aimed at treating cyclooxygenase-2 mediated disorders. This class of compounds includes benzopyrans, benzothiopyrans, dihydroquinolines, dihydronaphthalenes, and their analogs. The compounds of particular interest are defined by specific formulas, which detail the structural components necessary for their therapeutic efficacy.
Career Highlights
Throughout his career, Korte has worked with prominent companies in the pharmaceutical industry, including G.D. Searle & Company and Pharmacia Corporation, which is now part of Pfizer, Inc. His work in these organizations has allowed him to contribute to the development of innovative treatments that have the potential to improve patient outcomes.
Collaborations
Korte has collaborated with esteemed colleagues such as Jeffery S. Carter and Mark G. Obukowicz, further enhancing the impact of his research and inventions in the pharmaceutical field.
Conclusion
Donald E. Korte's innovative work in developing benzopyran derivatives showcases his commitment to advancing medical science. His contributions continue to influence the treatment of inflammation and highlight the importance of research in the pharmaceutical industry.